APT Neuroscience, Inc. (KOSDAQ:270520)

Kronos Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	248,947	223,101	273,753	110,948
Market Cap Growth	-53.47%	-18.50%	146.74%	-
Enterprise Value	273,395	155,739	237,291	-
Last Close Price	1286.00	1405.00	2185.00	1185.00
PS Ratio	12.40	12.14	13.41	6.32
PB Ratio	2.75	2.76	4.68	2.62
P/TBV Ratio	2.81	2.82	4.89	2.74
P/FCF Ratio	-	-	-	132.07
P/OCF Ratio	-	-	-	96.32
EV/Sales Ratio	13.62	8.47	11.62	-
Debt / Equity Ratio	1.11	1.21	0.51	0.38
Debt / FCF Ratio	-	-	-	19.02
Asset Turnover	0.13	0.12	0.25	-
Quick Ratio	0.64	1.48	1.79	2.24
Current Ratio	0.67	1.53	1.87	2.49
Return on Equity (ROE)	-11.43%	-27.51%	-9.93%	-
Return on Assets (ROA)	-5.35%	-5.23%	-5.12%	-
Return on Capital (ROIC)	-6.03%	-5.97%	-5.75%	-
Earnings Yield	-3.39%	-8.59%	-1.83%	-2.93%
FCF Yield	-18.18%	-4.82%	-3.18%	0.76%
Buyback Yield / Dilution	-23.72%	5.59%	-65.51%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.